688076 ST諾泰生物
按盤價 
39.620 +0.900 (+2.324%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 15.409 | 16.743 | 7.986 | 6.938 | 8.317 |
| 總資產報酬率 ROA (%) | 7.555 | 9.377 | 5.369 | 5.554 | 6.552 |
| 投入資產回報率 ROIC (%) | 8.297 | 10.302 | 5.879 | 6.009 | 7.142 | 邊際利潤分析 |
| 銷售毛利率 (%) | 68.463 | 67.685 | 60.970 | 57.573 | 55.756 |
| 營業利潤率 (%) | 32.212 | 27.586 | 18.351 | 19.170 | 19.928 |
| 息稅前利潤/營業總收入 (%) | 34.624 | 28.123 | 17.872 | 18.885 | 19.925 |
| 淨利潤/營業總收入 (%) | 29.224 | 24.607 | 16.008 | 18.850 | 16.899 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.835 | 112.187 | 119.143 | 84.003 | 103.928 |
| 價值變動淨收益/利潤總額(%) | 0.105 | -0.393 | 1.826 | 14.615 | 2.559 |
| 營業外收支淨額/利潤總額(%) | -0.099 | -2.215 | -9.553 | -1.375 | -2.054 | 償債能力分析 |
| 流動比率 (X) | 1.338 | 1.144 | 1.536 | 1.909 | 4.009 |
| 速動比率 (X) | 0.928 | 0.811 | 1.148 | 1.322 | 3.098 |
| 資產負債率 (%) | 53.151 | 47.178 | 38.282 | 23.685 | 14.958 |
| 帶息債務/全部投入資本 (%) | 44.500 | 38.053 | 29.919 | 15.173 | 6.859 |
| 股東權益/帶息債務 (%) | 114.507 | 151.528 | 224.103 | 545.882 | 1,326.533 |
| 股東權益/負債合計 (%) | 87.444 | 111.048 | 159.820 | 319.750 | 569.371 |
| 利息保障倍數 (X) | 14.170 | 24.778 | 15.938 | -752.242 | 50.102 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 107.538 | 91.715 | 94.334 | 106.360 | 68.995 |
| 存貨周轉天數 (天) | 399.465 | 329.524 | 312.642 | 374.107 | 275.370 |
| 備註： | 即時報價更新時間為 24/10/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
